Charles Schwab Investment Management Inc Celldex Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 538,856 shares of CLDX stock, worth $14.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
538,856
Previous 530,443 1.59%
Holding current value
$14.8 Million
Previous $19.6 Million 6.76%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$32.06 - $44.56 $269,720 - $374,883
8,413 Added 1.59%
538,856 $18.3 Million
Q2 2024

Aug 12, 2024
BUY
$32.76 - $42.56 $1.02 Million - $1.33 Million
31,222 Added 6.25%
530,443 $19.6 Million
Q1 2024

May 08, 2024
BUY
$35.22 - $51.88 $3.16 Million - $4.66 Million
89,830 Added 21.94%
499,221 $21 Million
Q4 2023

Feb 06, 2024
BUY
$22.61 - $40.65 $1.08 Million - $1.94 Million
47,844 Added 13.23%
409,391 $16.2 Million
Q3 2023

Nov 08, 2023
BUY
$25.45 - $37.46 $275,318 - $405,242
10,818 Added 3.08%
361,547 $9.95 Million
Q2 2023

Aug 09, 2023
BUY
$30.29 - $38.28 $121,341 - $153,349
4,006 Added 1.16%
350,729 $11.9 Million
Q1 2023

May 11, 2023
SELL
$34.78 - $47.43 $53,213 - $72,567
-1,530 Reduced 0.44%
346,723 $12.5 Million
Q4 2022

Feb 13, 2023
BUY
$27.78 - $45.38 $297,857 - $486,564
10,722 Added 3.18%
348,253 $15.5 Million
Q3 2022

Nov 14, 2022
BUY
$22.7 - $37.57 $158,264 - $261,938
6,972 Added 2.11%
337,531 $9.49 Million
Q2 2022

Aug 15, 2022
SELL
$20.5 - $37.33 $128,104 - $233,275
-6,249 Reduced 1.86%
330,559 $8.91 Million
Q1 2022

May 13, 2022
BUY
$27.64 - $39.32 $240,827 - $342,595
8,713 Added 2.66%
336,808 $11.5 Million
Q4 2021

Feb 11, 2022
BUY
$35.68 - $56.27 $201,199 - $317,306
5,639 Added 1.75%
328,095 $12.7 Million
Q3 2021

Nov 16, 2021
BUY
$28.95 - $55.99 $6.51 Million - $12.6 Million
224,831 Added 230.3%
322,456 $17.4 Million
Q2 2021

Aug 16, 2021
BUY
$20.71 - $35.37 $1.72 Million - $2.94 Million
83,116 Added 572.86%
97,625 $3.27 Million
Q4 2020

Feb 16, 2021
SELL
$14.99 - $22.75 $31,059 - $47,138
-2,072 Reduced 12.5%
14,509 $255,000
Q3 2020

Nov 13, 2020
BUY
$9.65 - $15.19 $160,006 - $251,865
16,581 New
16,581 $246,000

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.28B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email